nodes	percent_of_prediction	percent_of_DWPC	metapath
Sorafenib—thyroid cancer—mediastinal cancer	0.893	1	CtDrD
Sorafenib—RET—parathyroid gland—mediastinal cancer	0.00315	0.0318	CbGeAlD
Sorafenib—MAPK15—bronchus—mediastinal cancer	0.0019	0.0192	CbGeAlD
Sorafenib—MAPK15—thyroid gland—mediastinal cancer	0.00135	0.0136	CbGeAlD
Sorafenib—CDK7—hematopoietic system—mediastinal cancer	0.00123	0.0124	CbGeAlD
Sorafenib—ZAK—hematopoietic system—mediastinal cancer	0.00106	0.0107	CbGeAlD
Sorafenib—RET—Posttranslational regulation of adherens junction stability and dissassembly—PTPN1—mediastinal cancer	0.000998	0.128	CbGpPWpGaD
Sorafenib—TIE1—hematopoietic system—mediastinal cancer	0.000974	0.00983	CbGeAlD
Sorafenib—ZAK—bronchus—mediastinal cancer	0.000958	0.00967	CbGeAlD
Sorafenib—CSF1R—Signaling events mediated by TCPTP—PTPN1—mediastinal cancer	0.000956	0.123	CbGpPWpGaD
Sorafenib—RET—neck—mediastinal cancer	0.000954	0.00963	CbGeAlD
Sorafenib—HIPK3—bronchus—mediastinal cancer	0.000938	0.00946	CbGeAlD
Sorafenib—FLT3—hematopoietic system—mediastinal cancer	0.000886	0.00894	CbGeAlD
Sorafenib—CDK7—lymphoid tissue—mediastinal cancer	0.000867	0.00875	CbGeAlD
Sorafenib—FLT1—neck—mediastinal cancer	0.00084	0.00848	CbGeAlD
Sorafenib—RAF1—neck—mediastinal cancer	0.000835	0.00843	CbGeAlD
Sorafenib—FLT4—hematopoietic system—mediastinal cancer	0.000804	0.00812	CbGeAlD
Sorafenib—MAPK11—thyroid gland—mediastinal cancer	0.0008	0.00808	CbGeAlD
Sorafenib—HIPK3—cardiac atrium—mediastinal cancer	0.000791	0.00798	CbGeAlD
Sorafenib—CDK7—thyroid gland—mediastinal cancer	0.000788	0.00795	CbGeAlD
Sorafenib—TAOK2—thyroid gland—mediastinal cancer	0.000781	0.00789	CbGeAlD
Sorafenib—CSF1R—Signaling events mediated by PTP1B—PTPN1—mediastinal cancer	0.000775	0.0995	CbGpPWpGaD
Sorafenib—AURKC—thyroid gland—mediastinal cancer	0.000775	0.00783	CbGeAlD
Sorafenib—ZAK—lymphoid tissue—mediastinal cancer	0.000749	0.00756	CbGeAlD
Sorafenib—TIE1—cardiac atrium—mediastinal cancer	0.000739	0.00746	CbGeAlD
Sorafenib—MKNK2—hematopoietic system—mediastinal cancer	0.000728	0.00735	CbGeAlD
Sorafenib—MKNK1—hematopoietic system—mediastinal cancer	0.000719	0.00726	CbGeAlD
Sorafenib—CDK7—lung—mediastinal cancer	0.000715	0.00722	CbGeAlD
Sorafenib—FGFR1—bronchus—mediastinal cancer	0.000714	0.00721	CbGeAlD
Sorafenib—KDR—neck—mediastinal cancer	0.00071	0.00717	CbGeAlD
Sorafenib—RET—hematopoietic system—mediastinal cancer	0.00071	0.00717	CbGeAlD
Sorafenib—TAOK2—lung—mediastinal cancer	0.00071	0.00716	CbGeAlD
Sorafenib—ZAK—thyroid gland—mediastinal cancer	0.000681	0.00687	CbGeAlD
Sorafenib—MAP3K7—bronchus—mediastinal cancer	0.000676	0.00683	CbGeAlD
Sorafenib—HIPK3—bone marrow—mediastinal cancer	0.000668	0.00674	CbGeAlD
Sorafenib—HIPK3—thyroid gland—mediastinal cancer	0.000666	0.00672	CbGeAlD
Sorafenib—RALBP1—hematopoietic system—mediastinal cancer	0.000658	0.00664	CbGeAlD
Sorafenib—MKNK2—bronchus—mediastinal cancer	0.000656	0.00662	CbGeAlD
Sorafenib—MKNK1—bronchus—mediastinal cancer	0.000647	0.00653	CbGeAlD
Sorafenib—KIT—neck—mediastinal cancer	0.000629	0.00635	CbGeAlD
Sorafenib—FLT1—hematopoietic system—mediastinal cancer	0.000625	0.00631	CbGeAlD
Sorafenib—FLT3—lymphoid tissue—mediastinal cancer	0.000624	0.00629	CbGeAlD
Sorafenib—TIE1—thyroid gland—mediastinal cancer	0.000623	0.00628	CbGeAlD
Sorafenib—RAF1—hematopoietic system—mediastinal cancer	0.000622	0.00628	CbGeAlD
Sorafenib—ZAK—lung—mediastinal cancer	0.000618	0.00624	CbGeAlD
Sorafenib—KDR—Signaling events mediated by TCPTP—PTPN1—mediastinal cancer	0.000616	0.0791	CbGpPWpGaD
Sorafenib—PDGFRB—neck—mediastinal cancer	0.000615	0.00621	CbGeAlD
Sorafenib—MAP3K7—trachea—mediastinal cancer	0.000607	0.00613	CbGeAlD
Sorafenib—HIPK3—lung—mediastinal cancer	0.000605	0.00611	CbGeAlD
Sorafenib—FGFR1—cardiac atrium—mediastinal cancer	0.000603	0.00608	CbGeAlD
Sorafenib—BRAF—bone marrow—mediastinal cancer	0.000598	0.00604	CbGeAlD
Sorafenib—BRAF—thyroid gland—mediastinal cancer	0.000597	0.00602	CbGeAlD
Sorafenib—MAP3K19—lung—mediastinal cancer	0.000593	0.00598	CbGeAlD
Sorafenib—STK10—hematopoietic system—mediastinal cancer	0.000592	0.00598	CbGeAlD
Sorafenib—RALBP1—bronchus—mediastinal cancer	0.000592	0.00598	CbGeAlD
Sorafenib—MKNK2—trachea—mediastinal cancer	0.000589	0.00594	CbGeAlD
Sorafenib—PDGFRA—hematopoietic system—mediastinal cancer	0.000586	0.00592	CbGeAlD
Sorafenib—MAP3K7—cardiac atrium—mediastinal cancer	0.000571	0.00576	CbGeAlD
Sorafenib—EPHX2—thyroid gland—mediastinal cancer	0.00057	0.00576	CbGeAlD
Sorafenib—FLT3—bone marrow—mediastinal cancer	0.000568	0.00573	CbGeAlD
Sorafenib—FLT4—lymphoid tissue—mediastinal cancer	0.000566	0.00572	CbGeAlD
Sorafenib—TIE1—lung—mediastinal cancer	0.000565	0.00571	CbGeAlD
Sorafenib—FLT1—bronchus—mediastinal cancer	0.000563	0.00568	CbGeAlD
Sorafenib—RAF1—bronchus—mediastinal cancer	0.00056	0.00565	CbGeAlD
Sorafenib—UGT1A1—hematopoietic system—mediastinal cancer	0.000559	0.00564	CbGeAlD
Sorafenib—EPHB6—bronchus—mediastinal cancer	0.000557	0.00562	CbGeAlD
Sorafenib—MKNK2—cardiac atrium—mediastinal cancer	0.000553	0.00558	CbGeAlD
Sorafenib—MKNK1—cardiac atrium—mediastinal cancer	0.000546	0.00551	CbGeAlD
Sorafenib—BRAF—lung—mediastinal cancer	0.000542	0.00547	CbGeAlD
Sorafenib—STK10—bronchus—mediastinal cancer	0.000533	0.00538	CbGeAlD
Sorafenib—RALBP1—trachea—mediastinal cancer	0.000532	0.00537	CbGeAlD
Sorafenib—KDR—hematopoietic system—mediastinal cancer	0.000529	0.00534	CbGeAlD
Sorafenib—EPHX2—lung—mediastinal cancer	0.000518	0.00523	CbGeAlD
Sorafenib—CSF1R—hematopoietic system—mediastinal cancer	0.000516	0.00521	CbGeAlD
Sorafenib—FLT4—bone marrow—mediastinal cancer	0.000516	0.00521	CbGeAlD
Sorafenib—FLT3—lung—mediastinal cancer	0.000514	0.00519	CbGeAlD
Sorafenib—FLT4—thyroid gland—mediastinal cancer	0.000514	0.00519	CbGeAlD
Sorafenib—MKNK2—lymphoid tissue—mediastinal cancer	0.000513	0.00517	CbGeAlD
Sorafenib—FGFR1—thyroid gland—mediastinal cancer	0.000507	0.00512	CbGeAlD
Sorafenib—MKNK1—lymphoid tissue—mediastinal cancer	0.000506	0.00511	CbGeAlD
Sorafenib—FLT1—trachea—mediastinal cancer	0.000506	0.0051	CbGeAlD
Sorafenib—RAF1—trachea—mediastinal cancer	0.000503	0.00507	CbGeAlD
Sorafenib—RET—lymphoid tissue—mediastinal cancer	0.0005	0.00505	CbGeAlD
Sorafenib—EPHB6—trachea—mediastinal cancer	0.0005	0.00504	CbGeAlD
Sorafenib—RALBP1—cardiac atrium—mediastinal cancer	0.000499	0.00504	CbGeAlD
Sorafenib—MAPK11—lymph node—mediastinal cancer	0.000497	0.00502	CbGeAlD
Sorafenib—FGFR1—N-cadherin signaling events—PTPN1—mediastinal cancer	0.000493	0.0633	CbGpPWpGaD
Sorafenib—CDK7—lymph node—mediastinal cancer	0.000489	0.00494	CbGeAlD
Sorafenib—TAOK2—lymph node—mediastinal cancer	0.000485	0.0049	CbGeAlD
Sorafenib—MAP3K7—bone marrow—mediastinal cancer	0.000482	0.00486	CbGeAlD
Sorafenib—AURKC—lymph node—mediastinal cancer	0.000482	0.00486	CbGeAlD
Sorafenib—MAP3K7—thyroid gland—mediastinal cancer	0.00048	0.00485	CbGeAlD
Sorafenib—MAP2K5—bronchus—mediastinal cancer	0.000476	0.0048	CbGeAlD
Sorafenib—KDR—bronchus—mediastinal cancer	0.000476	0.0048	CbGeAlD
Sorafenib—FLT1—cardiac atrium—mediastinal cancer	0.000475	0.00479	CbGeAlD
Sorafenib—PDGFRA—trachea—mediastinal cancer	0.000474	0.00478	CbGeAlD
Sorafenib—RAF1—cardiac atrium—mediastinal cancer	0.000472	0.00477	CbGeAlD
Sorafenib—EPHB6—cardiac atrium—mediastinal cancer	0.000469	0.00474	CbGeAlD
Sorafenib—KIT—hematopoietic system—mediastinal cancer	0.000469	0.00473	CbGeAlD
Sorafenib—FLT4—lung—mediastinal cancer	0.000467	0.00472	CbGeAlD
Sorafenib—MKNK2—bone marrow—mediastinal cancer	0.000467	0.00471	CbGeAlD
Sorafenib—MKNK2—thyroid gland—mediastinal cancer	0.000466	0.0047	CbGeAlD
Sorafenib—CSF1R—bronchus—mediastinal cancer	0.000465	0.00469	CbGeAlD
Sorafenib—FGFR1—lung—mediastinal cancer	0.000461	0.00465	CbGeAlD
Sorafenib—MKNK1—bone marrow—mediastinal cancer	0.000461	0.00465	CbGeAlD
Sorafenib—MKNK1—thyroid gland—mediastinal cancer	0.00046	0.00464	CbGeAlD
Sorafenib—PDGFRB—hematopoietic system—mediastinal cancer	0.000458	0.00462	CbGeAlD
Sorafenib—RAF1—IGF1 pathway—PTPN1—mediastinal cancer	0.000457	0.0586	CbGpPWpGaD
Sorafenib—RET—thyroid gland—mediastinal cancer	0.000454	0.00458	CbGeAlD
Sorafenib—FLT1—lymphoid tissue—mediastinal cancer	0.00044	0.00444	CbGeAlD
Sorafenib—RAF1—lymphoid tissue—mediastinal cancer	0.000438	0.00442	CbGeAlD
Sorafenib—MAP3K7—lung—mediastinal cancer	0.000436	0.0044	CbGeAlD
Sorafenib—MAP2K5—trachea—mediastinal cancer	0.000427	0.00431	CbGeAlD
Sorafenib—KDR—trachea—mediastinal cancer	0.000427	0.00431	CbGeAlD
Sorafenib—MKNK2—lung—mediastinal cancer	0.000423	0.00427	CbGeAlD
Sorafenib—ZAK—lymph node—mediastinal cancer	0.000423	0.00427	CbGeAlD
Sorafenib—KIT—bronchus—mediastinal cancer	0.000422	0.00426	CbGeAlD
Sorafenib—RALBP1—bone marrow—mediastinal cancer	0.000422	0.00426	CbGeAlD
Sorafenib—RALBP1—thyroid gland—mediastinal cancer	0.00042	0.00424	CbGeAlD
Sorafenib—MKNK1—lung—mediastinal cancer	0.000418	0.00421	CbGeAlD
Sorafenib—CSF1R—trachea—mediastinal cancer	0.000417	0.00421	CbGeAlD
Sorafenib—STK10—lymphoid tissue—mediastinal cancer	0.000417	0.00421	CbGeAlD
Sorafenib—HIPK3—lymph node—mediastinal cancer	0.000414	0.00418	CbGeAlD
Sorafenib—PDGFRA—lymphoid tissue—mediastinal cancer	0.000413	0.00417	CbGeAlD
Sorafenib—PDGFRB—bronchus—mediastinal cancer	0.000412	0.00416	CbGeAlD
Sorafenib—PDGFRB—Signaling events mediated by TCPTP—PTPN1—mediastinal cancer	0.000408	0.0523	CbGpPWpGaD
Sorafenib—MAP2K5—cardiac atrium—mediastinal cancer	0.000401	0.00405	CbGeAlD
Sorafenib—KDR—cardiac atrium—mediastinal cancer	0.000401	0.00405	CbGeAlD
Sorafenib—FLT1—thyroid gland—mediastinal cancer	0.0004	0.00404	CbGeAlD
Sorafenib—RAF1—bone marrow—mediastinal cancer	0.000399	0.00402	CbGeAlD
Sorafenib—RAF1—thyroid gland—mediastinal cancer	0.000398	0.00401	CbGeAlD
Sorafenib—EPHB6—thyroid gland—mediastinal cancer	0.000395	0.00399	CbGeAlD
Sorafenib—CSF1R—cardiac atrium—mediastinal cancer	0.000392	0.00395	CbGeAlD
Sorafenib—TIE1—lymph node—mediastinal cancer	0.000387	0.0039	CbGeAlD
Sorafenib—RALBP1—lung—mediastinal cancer	0.000382	0.00386	CbGeAlD
Sorafenib—STK10—bone marrow—mediastinal cancer	0.00038	0.00383	CbGeAlD
Sorafenib—KIT—trachea—mediastinal cancer	0.000379	0.00382	CbGeAlD
Sorafenib—STK10—thyroid gland—mediastinal cancer	0.000379	0.00382	CbGeAlD
Sorafenib—PDGFRA—thyroid gland—mediastinal cancer	0.000375	0.00378	CbGeAlD
Sorafenib—KDR—lymphoid tissue—mediastinal cancer	0.000372	0.00376	CbGeAlD
Sorafenib—BRAF—lymph node—mediastinal cancer	0.000371	0.00374	CbGeAlD
Sorafenib—PDGFRB—trachea—mediastinal cancer	0.00037	0.00373	CbGeAlD
Sorafenib—ABCC4—hematopoietic system—mediastinal cancer	0.000364	0.00368	CbGeAlD
Sorafenib—CSF1R—lymphoid tissue—mediastinal cancer	0.000363	0.00367	CbGeAlD
Sorafenib—FLT1—lung—mediastinal cancer	0.000363	0.00367	CbGeAlD
Sorafenib—RAF1—lung—mediastinal cancer	0.000361	0.00365	CbGeAlD
Sorafenib—EPHB6—lung—mediastinal cancer	0.000359	0.00362	CbGeAlD
Sorafenib—EPHX2—lymph node—mediastinal cancer	0.000354	0.00358	CbGeAlD
Sorafenib—FLT3—lymph node—mediastinal cancer	0.000352	0.00355	CbGeAlD
Sorafenib—PDGFRB—cardiac atrium—mediastinal cancer	0.000348	0.00351	CbGeAlD
Sorafenib—STK10—lung—mediastinal cancer	0.000344	0.00347	CbGeAlD
Sorafenib—PDGFRA—lung—mediastinal cancer	0.00034	0.00344	CbGeAlD
Sorafenib—KDR—bone marrow—mediastinal cancer	0.000339	0.00342	CbGeAlD
Sorafenib—KDR—thyroid gland—mediastinal cancer	0.000338	0.00341	CbGeAlD
Sorafenib—MAP2K5—thyroid gland—mediastinal cancer	0.000338	0.00341	CbGeAlD
Sorafenib—CSF1R—bone marrow—mediastinal cancer	0.000331	0.00334	CbGeAlD
Sorafenib—PDGFRB—Signaling events mediated by PTP1B—PTPN1—mediastinal cancer	0.00033	0.0424	CbGpPWpGaD
Sorafenib—CSF1R—thyroid gland—mediastinal cancer	0.00033	0.00333	CbGeAlD
Sorafenib—KIT—lymphoid tissue—mediastinal cancer	0.00033	0.00333	CbGeAlD
Sorafenib—ABCC4—bronchus—mediastinal cancer	0.000328	0.00331	CbGeAlD
Sorafenib—PDGFRB—lymphoid tissue—mediastinal cancer	0.000322	0.00325	CbGeAlD
Sorafenib—FLT4—lymph node—mediastinal cancer	0.00032	0.00323	CbGeAlD
Sorafenib—FGFR1—lymph node—mediastinal cancer	0.000315	0.00318	CbGeAlD
Sorafenib—MAP2K5—lung—mediastinal cancer	0.000307	0.0031	CbGeAlD
Sorafenib—KDR—lung—mediastinal cancer	0.000307	0.0031	CbGeAlD
Sorafenib—CYP2C19—hematopoietic system—mediastinal cancer	0.000303	0.00306	CbGeAlD
Sorafenib—KIT—bone marrow—mediastinal cancer	0.0003	0.00303	CbGeAlD
Sorafenib—CSF1R—lung—mediastinal cancer	0.0003	0.00303	CbGeAlD
Sorafenib—KIT—thyroid gland—mediastinal cancer	0.0003	0.00302	CbGeAlD
Sorafenib—MAP3K7—lymph node—mediastinal cancer	0.000298	0.00301	CbGeAlD
Sorafenib—PDGFRB—bone marrow—mediastinal cancer	0.000293	0.00296	CbGeAlD
Sorafenib—PDGFRB—thyroid gland—mediastinal cancer	0.000293	0.00295	CbGeAlD
Sorafenib—MKNK2—lymph node—mediastinal cancer	0.000289	0.00292	CbGeAlD
Sorafenib—MKNK1—lymph node—mediastinal cancer	0.000286	0.00288	CbGeAlD
Sorafenib—RET—lymph node—mediastinal cancer	0.000282	0.00285	CbGeAlD
Sorafenib—KIT—lung—mediastinal cancer	0.000272	0.00275	CbGeAlD
Sorafenib—PDGFRB—lung—mediastinal cancer	0.000266	0.00268	CbGeAlD
Sorafenib—CYP2C8—hematopoietic system—mediastinal cancer	0.000265	0.00267	CbGeAlD
Sorafenib—RALBP1—lymph node—mediastinal cancer	0.000261	0.00264	CbGeAlD
Sorafenib—FLT1—lymph node—mediastinal cancer	0.000248	0.00251	CbGeAlD
Sorafenib—CYP1A2—hematopoietic system—mediastinal cancer	0.000248	0.0025	CbGeAlD
Sorafenib—RAF1—lymph node—mediastinal cancer	0.000247	0.00249	CbGeAlD
Sorafenib—EPHB6—lymph node—mediastinal cancer	0.000246	0.00248	CbGeAlD
Sorafenib—CYP3A5—hematopoietic system—mediastinal cancer	0.000239	0.00241	CbGeAlD
Sorafenib—CYP2B6—hematopoietic system—mediastinal cancer	0.000237	0.0024	CbGeAlD
Sorafenib—STK10—lymph node—mediastinal cancer	0.000235	0.00237	CbGeAlD
Sorafenib—CYP2C9—hematopoietic system—mediastinal cancer	0.000235	0.00237	CbGeAlD
Sorafenib—ABCC4—bone marrow—mediastinal cancer	0.000234	0.00236	CbGeAlD
Sorafenib—ABCC4—thyroid gland—mediastinal cancer	0.000233	0.00235	CbGeAlD
Sorafenib—PDGFRA—lymph node—mediastinal cancer	0.000233	0.00235	CbGeAlD
Sorafenib—HTR2B—thyroid gland—mediastinal cancer	0.000232	0.00234	CbGeAlD
Sorafenib—RAF1—Leptin signaling pathway—PTPN1—mediastinal cancer	0.00022	0.0282	CbGpPWpGaD
Sorafenib—CYP2B6—bronchus—mediastinal cancer	0.000214	0.00216	CbGeAlD
Sorafenib—ABCC4—lung—mediastinal cancer	0.000212	0.00214	CbGeAlD
Sorafenib—BRAF—PDGFR-beta signaling pathway—PTPN1—mediastinal cancer	0.000211	0.0271	CbGpPWpGaD
Sorafenib—HTR2B—lung—mediastinal cancer	0.000211	0.00212	CbGeAlD
Sorafenib—MAP2K5—lymph node—mediastinal cancer	0.00021	0.00212	CbGeAlD
Sorafenib—KDR—lymph node—mediastinal cancer	0.00021	0.00212	CbGeAlD
Sorafenib—RAF1—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—PTPN1—mediastinal cancer	0.000209	0.0268	CbGpPWpGaD
Sorafenib—MAP2K5—Insulin Signaling—PTPN1—mediastinal cancer	0.000209	0.0268	CbGpPWpGaD
Sorafenib—CSF1R—lymph node—mediastinal cancer	0.000205	0.00207	CbGeAlD
Sorafenib—KIT—lymph node—mediastinal cancer	0.000186	0.00188	CbGeAlD
Sorafenib—PDGFRB—lymph node—mediastinal cancer	0.000182	0.00183	CbGeAlD
Sorafenib—CYP3A4—hematopoietic system—mediastinal cancer	0.000179	0.00181	CbGeAlD
Sorafenib—CYP2D6—hematopoietic system—mediastinal cancer	0.000176	0.00178	CbGeAlD
Sorafenib—MAPK11—Insulin Signaling—PTPN1—mediastinal cancer	0.000175	0.0224	CbGpPWpGaD
Sorafenib—CYP2B6—lymphoid tissue—mediastinal cancer	0.000167	0.00169	CbGeAlD
Sorafenib—ABCG2—bone marrow—mediastinal cancer	0.000165	0.00166	CbGeAlD
Sorafenib—ABCG2—thyroid gland—mediastinal cancer	0.000164	0.00166	CbGeAlD
Sorafenib—PDGFRB—PDGFR-beta signaling pathway—PTPN1—mediastinal cancer	0.000164	0.021	CbGpPWpGaD
Sorafenib—CYP1A2—thyroid gland—mediastinal cancer	0.000158	0.0016	CbGeAlD
Sorafenib—MAP3K7—Insulin Signaling—PTPN1—mediastinal cancer	0.000158	0.0202	CbGpPWpGaD
Sorafenib—ABCG2—lung—mediastinal cancer	0.000149	0.00151	CbGeAlD
Sorafenib—RAF1—PDGFR-beta signaling pathway—PTPN1—mediastinal cancer	0.000146	0.0187	CbGpPWpGaD
Sorafenib—ABCC4—lymph node—mediastinal cancer	0.000145	0.00146	CbGeAlD
Sorafenib—HTR2B—lymph node—mediastinal cancer	0.000144	0.00145	CbGeAlD
Sorafenib—CYP1A2—lung—mediastinal cancer	0.000144	0.00145	CbGeAlD
Sorafenib—ABCC2—lymph node—mediastinal cancer	0.00014	0.00141	CbGeAlD
Sorafenib—CYP3A5—lung—mediastinal cancer	0.000139	0.0014	CbGeAlD
Sorafenib—CYP2B6—lung—mediastinal cancer	0.000138	0.00139	CbGeAlD
Sorafenib—ABCB1—hematopoietic system—mediastinal cancer	0.000127	0.00128	CbGeAlD
Sorafenib—RAF1—Insulin Signaling—PTPN1—mediastinal cancer	0.00012	0.0154	CbGpPWpGaD
Sorafenib—ABCC4—Platelet activation, signaling and aggregation—PTPN1—mediastinal cancer	0.00011	0.0141	CbGpPWpGaD
Sorafenib—ABCB1—trachea—mediastinal cancer	0.000103	0.00103	CbGeAlD
Sorafenib—ABCG2—lymph node—mediastinal cancer	0.000102	0.00103	CbGeAlD
Sorafenib—MAP3K7—Cytokine Signaling in Immune system—PTPN1—mediastinal cancer	0.000101	0.0129	CbGpPWpGaD
Sorafenib—RAF1—Platelet activation, signaling and aggregation—PTPN1—mediastinal cancer	9.25e-05	0.0119	CbGpPWpGaD
Sorafenib—ABCB1—lymphoid tissue—mediastinal cancer	8.93e-05	0.000901	CbGeAlD
Sorafenib—ABCB1—bone marrow—mediastinal cancer	8.13e-05	0.000821	CbGeAlD
Sorafenib—ABCB1—thyroid gland—mediastinal cancer	8.11e-05	0.000819	CbGeAlD
Sorafenib—RAF1—Cytokine Signaling in Immune system—PTPN1—mediastinal cancer	7.66e-05	0.00982	CbGpPWpGaD
Sorafenib—ABCB1—lung—mediastinal cancer	7.37e-05	0.000744	CbGeAlD
Sorafenib—ABCC4—Hemostasis—PTPN1—mediastinal cancer	5.67e-05	0.00728	CbGpPWpGaD
Sorafenib—RALBP1—Signaling Pathways—PTPN1—mediastinal cancer	5.62e-05	0.00721	CbGpPWpGaD
Sorafenib—FLT4—Signaling Pathways—PTPN1—mediastinal cancer	5.53e-05	0.00709	CbGpPWpGaD
Sorafenib—ABCB1—lymph node—mediastinal cancer	5.04e-05	0.000509	CbGeAlD
Sorafenib—RAF1—Hemostasis—PTPN1—mediastinal cancer	4.77e-05	0.00612	CbGpPWpGaD
Sorafenib—MKNK1—Signaling Pathways—PTPN1—mediastinal cancer	4.58e-05	0.00587	CbGpPWpGaD
Sorafenib—FLT1—Signaling Pathways—PTPN1—mediastinal cancer	4.12e-05	0.00529	CbGpPWpGaD
Sorafenib—MAPK11—Immune System—PTPN1—mediastinal cancer	3.65e-05	0.00468	CbGpPWpGaD
Sorafenib—KIT—Immune System—PTPN1—mediastinal cancer	3.29e-05	0.00422	CbGpPWpGaD
Sorafenib—MAP3K7—Immune System—PTPN1—mediastinal cancer	3.29e-05	0.00422	CbGpPWpGaD
Sorafenib—FGFR1—Immune System—PTPN1—mediastinal cancer	3.12e-05	0.00401	CbGpPWpGaD
Sorafenib—PDGFRA—Immune System—PTPN1—mediastinal cancer	3.11e-05	0.004	CbGpPWpGaD
Sorafenib—MAP2K5—Signaling Pathways—PTPN1—mediastinal cancer	2.82e-05	0.00361	CbGpPWpGaD
Sorafenib—PDGFRB—Immune System—PTPN1—mediastinal cancer	2.81e-05	0.0036	CbGpPWpGaD
Sorafenib—KDR—Signaling Pathways—PTPN1—mediastinal cancer	2.74e-05	0.00352	CbGpPWpGaD
Sorafenib—RAF1—Immune System—PTPN1—mediastinal cancer	2.5e-05	0.00321	CbGpPWpGaD
Sorafenib—MAPK11—Signaling Pathways—PTPN1—mediastinal cancer	2.36e-05	0.00303	CbGpPWpGaD
Sorafenib—BRAF—Signaling Pathways—PTPN1—mediastinal cancer	2.34e-05	0.003	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—PTPN1—mediastinal cancer	2.13e-05	0.00273	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—PTPN1—mediastinal cancer	2.13e-05	0.00273	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—PTPN1—mediastinal cancer	2.02e-05	0.00259	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—PTPN1—mediastinal cancer	2.01e-05	0.00258	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—PTPN1—mediastinal cancer	1.81e-05	0.00233	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—PTPN1—mediastinal cancer	1.73e-05	0.00222	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—PTPN1—mediastinal cancer	1.62e-05	0.00207	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—PTPN1—mediastinal cancer	1.4e-05	0.00179	CbGpPWpGaD
